Blocking FDA approval of abortion pill could stifle innovation in the biopharma industry, experts say

A complicated legal fight over abortion pill mifepristone could reduce innovation in the biopharma industry, companies and experts in law and economics said.

from US Top News and Analysis https://ift.tt/lFNRQvT
https://ift.tt/vBspb26